198 related articles for article (PubMed ID: 31305527)
1. Human Neural Organoids for Studying Brain Cancer and Neurodegenerative Diseases.
Cosset E; Locatelli M; Marteyn A; Lescuyer P; Dall Antonia F; Mor FM; Preynat-Seauve O; Stoppini L; Tieng V
J Vis Exp; 2019 Jun; (148):. PubMed ID: 31305527
[TBL] [Abstract][Full Text] [Related]
2. Use of 3D Organoids as a Model to Study Idiopathic Form of Parkinson's Disease.
Chlebanowska P; Tejchman A; Sułkowski M; Skrzypek K; Majka M
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31973095
[TBL] [Abstract][Full Text] [Related]
3. Derivation of Human Midbrain-Specific Organoids from Neuroepithelial Stem Cells.
Monzel AS; Smits LM; Hemmer K; Hachi S; Moreno EL; van Wuellen T; Jarazo J; Walter J; Brüggemann I; Boussaad I; Berger E; Fleming RMT; Bolognin S; Schwamborn JC
Stem Cell Reports; 2017 May; 8(5):1144-1154. PubMed ID: 28416282
[TBL] [Abstract][Full Text] [Related]
4. Organoid and pluripotent stem cells in Parkinson's disease modeling: an expert view on their value to drug discovery.
Marotta N; Kim S; Krainc D
Expert Opin Drug Discov; 2020 Apr; 15(4):427-441. PubMed ID: 31899983
[No Abstract] [Full Text] [Related]
5. Neural stem cells derived from human midbrain organoids as a stable source for treating Parkinson's disease: Midbrain organoid-NSCs (Og-NSC) as a stable source for PD treatment.
Kim SW; Woo HJ; Kim EH; Kim HS; Suh HN; Kim SH; Song JJ; Wulansari N; Kang M; Choi SY; Choi SJ; Jang WH; Lee J; Kim KH; Lee W; Kim SH; Yang J; Kyung J; Lee HS; Park SM; Chang MY; Lee SH
Prog Neurobiol; 2021 Sep; 204():102086. PubMed ID: 34052305
[TBL] [Abstract][Full Text] [Related]
6. Implications of Parkinson's disease pathophysiology for the development of cell replacement strategies and drug discovery in neurodegenerative diseases.
Pan-Montojo F; Funk RH
CNS Neurol Disord Drug Targets; 2012 Nov; 11(7):907-20. PubMed ID: 23131153
[TBL] [Abstract][Full Text] [Related]
7. Reproducible generation of human midbrain organoids for in vitro modeling of Parkinson's disease.
Nickels SL; Modamio J; Mendes-Pinheiro B; Monzel AS; Betsou F; Schwamborn JC
Stem Cell Res; 2020 Jul; 46():101870. PubMed ID: 32534166
[TBL] [Abstract][Full Text] [Related]
8. From stem cells to dopamine neurons: developmental biology meets neurodegeneration.
Tailor J; Andreska T; Kittappa R
CNS Neurol Disord Drug Targets; 2012 Nov; 11(7):893-6. PubMed ID: 23131155
[TBL] [Abstract][Full Text] [Related]
9. Engineering of midbrain organoids containing long-lived dopaminergic neurons.
Tieng V; Stoppini L; Villy S; Fathi M; Dubois-Dauphin M; Krause KH
Stem Cells Dev; 2014 Jul; 23(13):1535-47. PubMed ID: 24576173
[TBL] [Abstract][Full Text] [Related]
10. Opportunities and challenges for the use of induced pluripotent stem cells in modelling neurodegenerative disease.
Wu YY; Chiu FL; Yeh CS; Kuo HC
Open Biol; 2019 Jan; 9(1):180177. PubMed ID: 30958120
[TBL] [Abstract][Full Text] [Related]
11. Immature Midbrain Dopaminergic Neurons Derived from Floor-Plate Method Improve Cell Transplantation Therapy Efficacy for Parkinson's Disease.
Qiu L; Liao MC; Chen AK; Wei S; Xie S; Reuveny S; Zhou ZD; Hunziker W; Tan EK; Oh SKW; Zeng L
Stem Cells Transl Med; 2017 Sep; 6(9):1803-1814. PubMed ID: 28650520
[TBL] [Abstract][Full Text] [Related]
12. Dopaminergic differentiation using pluripotent stem cells.
Momčilović O; Montoya-Sack J; Zeng X
J Cell Biochem; 2012 Dec; 113(12):3610-9. PubMed ID: 22807388
[TBL] [Abstract][Full Text] [Related]
13. Modeling G2019S-LRRK2 Sporadic Parkinson's Disease in 3D Midbrain Organoids.
Kim H; Park HJ; Choi H; Chang Y; Park H; Shin J; Kim J; Lengner CJ; Lee YK; Kim J
Stem Cell Reports; 2019 Mar; 12(3):518-531. PubMed ID: 30799274
[TBL] [Abstract][Full Text] [Related]
14. Modelling neurodegenerative diseases with 3D brain organoids.
Chang Y; Kim J; Park H; Choi H; Kim J
Biol Rev Camb Philos Soc; 2020 Oct; 95(5):1497-1509. PubMed ID: 32568450
[TBL] [Abstract][Full Text] [Related]
15. Establishment of 3D Neuro-Organoids Derived from Pig Embryonic Stem-Like Cells.
Hwang SU; Eun K; Kim M; Yoon JD; Cai L; Choi H; Oh D; Lee G; Kim H; Kim E; Hyun SH
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33807555
[TBL] [Abstract][Full Text] [Related]
16. Strategies for bringing stem cell-derived dopamine neurons to the clinic-The NYSTEM trial.
Studer L
Prog Brain Res; 2017; 230():191-212. PubMed ID: 28552229
[TBL] [Abstract][Full Text] [Related]
17. Dopaminergic precursors differentiated from human blood-derived induced neural stem cells improve symptoms of a mouse Parkinson's disease model.
Yuan Y; Tang X; Bai YF; Wang S; An J; Wu Y; Xu ZD; Zhang YA; Chen Z
Theranostics; 2018; 8(17):4679-4694. PubMed ID: 30279731
[TBL] [Abstract][Full Text] [Related]
18. Three-dimensional modeling of human neurodegeneration: brain organoids coming of age.
Grenier K; Kao J; Diamandis P
Mol Psychiatry; 2020 Feb; 25(2):254-274. PubMed ID: 31444473
[TBL] [Abstract][Full Text] [Related]
19. 3D cultures of human neural progenitor cells: dopaminergic differentiation and genetic modification. [corrected].
Brito C; Simão D; Costa I; Malpique R; Pereira CI; Fernandes P; Serra M; Schwarz SC; Schwarz J; Kremer EJ; Alves PM
Methods; 2012 Mar; 56(3):452-60. PubMed ID: 22433395
[TBL] [Abstract][Full Text] [Related]
20. Distinctive genomic signature of neural and intestinal organoids from familial Parkinson's disease patient-derived induced pluripotent stem cells.
Son MY; Sim H; Son YS; Jung KB; Lee MO; Oh JH; Chung SK; Jung CR; Kim J
Neuropathol Appl Neurobiol; 2017 Dec; 43(7):584-603. PubMed ID: 28235153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
